Engineered nano-aircraft carrier enhances tumor targeting and immune response

Verge Ge­nomics has se­cured its largest deal yet, link­ing up with As­traZeneca’s rare dis­ease di­vi­sion Alex­ion in a deal worth up to $882 mil­lion. The

Trust in the phar­ma in­dus­try is up among con­sumers, but slipped for the biotech sec­tor in an un­usu­al flip of sen­ti­ment about the two in­dus­tries,